By Stewart Bishop ( April 9, 2012, 8:47 PM EDT) -- Teva Pharmaceuticals USA Inc. on Friday moved to toss direct purchasers' claims in multiple class actions and individual suits accusing it of conspiring with Wyeth LLC to delay a generic antidepressant's entry into the market, arguing that settling patent litigation with Wyeth didn't violate antitrust law....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.